Cannabis-Focused Finance Company Altmore Capital Files For Nasdaq IPO

Specialty finance company Altmore BDC, Inc., also known as Altmore Capital, is looking to go public on the Nasdaq Capital Market. The firm announced today the launch of its initial public offering of 6.67 million common shares.

The firm is targeting the share price between US$14.50 and US$15.50 per share, which puts target proceeds from the offering at US$103.3 million on the high end of the range.

The shares are expected to trade on the Nasdaq big board under the symbol “ABDC”. The underwriters also have a 30-day over-allotment option to purchase additional 1.0 million shares.

The proceeds from the offering are intended for investments in senior secured loans and general working capital purposes.

The finance firm services loans primarily to cannabis operators in the United States, including cultivators, processors, manufacturers, distributors, and retailers.


Information for this briefing was found via Edgar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Why $100 Silver Right Now Would Be a Problem | Keith Neumeyer – First Majestic

Why Industrial Demand Is Changing the Silver Market | David Morgan

Gold and Silver Delivery Is Exposing the Paper Market | Andy Schectman

Recommended

Nations Royalty Names Derrick Pattenden As President And CEO

First Phosphate Receives US$530,000 Pre-Payment Under Offtake Agreement

Related News

Wellness Firm The Better Being Co. Launches US$213 Million IPO

Whole-body wellness enterprise The Better Being Co. announced today the launch of its initial public...

Monday, July 26, 2021, 11:30:00 AM

Biopharma Absci Prices US$200 Million IPO

Synthetic biology company Absci Corporation began trading on the Nasdaq Global Select Market today under...

Thursday, July 22, 2021, 12:43:00 PM

Biopharmaceutical Firm Candel Therapeutics Prices Downsized US$72 Million IPO

Late clinical stage biopharmaceutical company Candel Therapeutics Inc. (Nasdaq: CADL) started publicly trading on the...

Tuesday, July 27, 2021, 10:47:00 AM

Healthcare SPAC DTRT Health Acquisition Prices US$200 Million IPO

Blank check company DTRT Health Acquisition Corp. (Nasdaq: DTRTU) went public today on the Nasdaq...

Thursday, September 2, 2021, 12:57:00 PM

Railroad SPAC Integrated Rail and Resources Acquisition Prices US$200 Million IPO

Special purpose acquisition company Integrated Rail and Resources Acquisition Corp. (NYSE: IRRXU) went public today...

Friday, November 12, 2021, 02:10:00 PM